OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.
Lantibiotics continue to offer an untapped pipeline for the development of novel antibiotics. We report here the discovery of a novel lantibiotic for the treatment of C. difficile infection (CDI). The leads were selected from a library of over 300 multiple substitution variants of the lantibiotic Mu...
Saved in: